Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access Highly Access

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

Xiongpeng Zhu*, Yuehua Ma and Delong Liu*

Journal of Hematology & Oncology 2010, 3:17 doi:10.1186/1756-8722-3-17

Accesses  

  • Last 30 days: 118 accesses
  • Last 365 days: 1553 accesses
  • All time: 6497 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

Guoqing Wei, Wanmao Ni, Jen-wei Chiao, Zhen Cai, He Huang, Delong Liu Journal of Hematology & Oncology 2011, 4:46 (14 November 2011)

Abstract | Full text | PDF | PubMed

Review   Open Access Highly Accessed

Current findings for recurring mutations in acute myeloid leukemia

Shinichiro Takahashi Journal of Hematology & Oncology 2011, 4:36 (14 September 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations